Healix Infusion Therapy, Incor v. Heartland Home Infusions, Inc.

733 F.3d 700, 2013 WL 4317142, 2013 U.S. App. LEXIS 17125
CourtCourt of Appeals for the Seventh Circuit
DecidedAugust 16, 2013
Docket12-3768
StatusPublished
Cited by8 cases

This text of 733 F.3d 700 (Healix Infusion Therapy, Incor v. Heartland Home Infusions, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Healix Infusion Therapy, Incor v. Heartland Home Infusions, Inc., 733 F.3d 700, 2013 WL 4317142, 2013 U.S. App. LEXIS 17125 (7th Cir. 2013).

Opinion

EASTERBROOK, Chief Judge.

Healix Infusion Therapy, Inc., and HHI Infusion Services compete in’ the infusion therapy services business. Infusion therapy is the administration of substances such as pharmaceuticals intravenously or by any method other than ingestion. Some medical care providers wish to offer these services to patients in the office of their medical practice. For instance, an oncologist’s office might have an area where patients can receive intravenous chemotherapy. Healix and HHI provide support: premixed pharmaceuticals, nurses to administer the drugs, billing services, and other necessities of an’ in-office infusion therapy center. Their customers are physicians and medical practices.

In June 2007 Healix recruited 3 Tree Infectious Disease Clinic, LLC (the Clinic), a medical practice in Burien, Washington, as a new customer. The Clinic had two members: David Keller, a physician, and Chris Porter, a nurse practitioner. Healix and the Clinic signed a five-year contract, under which Healix would provide infusion services after the Clinic built an in-office pharmacy and hired staff to work there. The Clinic was responsible for the expense of constructing the pharmacy. Healix required Keller and Porter to execute personal guarantees, and it took a security interest in some of the'Clinic’s accounts receivable.

The arrangement did not last long. Four months after signing the contract, the Clinic sent a letter informing Healix that it would not fulfill its responsibilities. The contract does not allow termination at will; HHI does not contest Healix’s assertion that the Clinic was in breach — though Healix did not sue the Clinic or seek a remedy outside of the >>judicial system. One month after sending..’this letter, the Clinic- entered into a contract for infusion services with HHI. The two businesses *702 first met at the Infectious Disease Society Association’s.annual conference in October 2007. Porter spoke with Landon Lackey, one of HHI’s employees, at its booth and later at a cocktail party HHI had organized.

When Healix found out that the Clinic had signed with a rival, it sued HHI for copyright and trademark infringement and for tortious interference with a contract. The intellectual-property claims were dismissed. The tortious-interference claim continued. (The district judge could not send it to state court under 28 U.S.C. § 1367(c), because the parties meet , the requirements of the diversity jurisdiction.) The parties agree that the tort claim is governed by Texas law. The court held a bench trial and ruled against Healix.

Healix maintained .at trial that, during the October 2007. conference, Lackey either learned that Healix had a contract with the Clinic or learned facts that would have led a reasonable person.in his position to conclude that a contract existed. Despite that knowledge, Healix contended, Lackey and HHI sought the Clinic’s business, offering a contract that did not require the Clinic to build an in-office pharmacy, hire additional employees, or provide personal guarantees. The Clinic took HHI’s offer, which on balance was superior to Healix’s, and broke its promise to Healix.

Under Texas law, to demonstrate tortious interference with a contract Healix must show “(1) that a contract subject to interference exists; (2) that:the alleged act of interference was willful and intentional; (3) that the willful and intentional act caused damage; : and (4) that actual damage or loss occurred.” ACS Investors, Inc. v. McLaughlin, 943 S.W.2d 426, 430 (Tex.1997). If the facts are as Healix narrates them; it might have a good claim for tortious interference with a contract. Its problem, however, is that the district judge did not find the facts to be so.

Healix presented three main kinds of evidence: first, the testimony of Porter, who said that he told Lackey about the contract at the October 2007 conference; second, the UCC statement that Healix filed with Washington’s Secretary of State; third, Lackey’s testimony. Lackey was called as an adverse witness and .professed not to remember what he talked about with Porter at the conference. HHI’s main evidence was the testimony of Healix’s other owner, David Keller, who stated that an in-office pharmacy would have been too costly. The district court found that Healix “would not have performed under the contract under any circumstances ... [because] Keller was profoundly uncomfortable with the financial obligations imposed by the contract and he would not do what he needed to do to make the deal with Healix work”. 2012 WL 5988870 at *2, 2012 U.S. Dist. Lexis 169376 at *4-5 (N.D.Ill. Nov. 29, 2012). HHI also called Neil Stanton, who attended the October 2007 conference with Lackey and expressed confidence that he would remember whether Porter told him about having a contract with Healix; he had no recollection of it.

The district judge found Porter’s testimony not credible: “Porter’s demeanor was unusual and his mannerisms disclosed many of the classic indicia of untruthfulness. I. conclude from my observation of Porter’s demeanor that he had significant blanks in his recollection, which he tried to fill in by telling a story of what might have happened.” Id. at *2, 2012 U.S. Dist. Lexis 169376 at *4. As we have mentioned, the judge did believe Keller. In addition to its credibility findings, the court found that the financing statement did not alert HHI to the contract’s existence.

Healix contends that the judge made three errors. Without them, it argues, the *703 district court should have found that HHI tortiously interfered with its contract. First, Healix argues, the court misapplied Texas law by not fully appreciating that it does not require the defendant to have had direct knowledge of the contract. Rather, the knowledge requirement is satisfied if the interfering party had knowledge of “facts from which a reasonable person would conclude the existence of a contract.” Kelly v. Galveston County, 520 S.W.2d 507, 513 (Tex.Civ.App.1975). Second, Healix argues that the judge overlooked evidence showing that a reasonable person in Lackey’s position would have known that the Clinic had a contract, with Healix. Finally, Healix contends that the court erred in finding that Healix could not show causation, and it argues that it demonstrated that the Clinic broke its contract because HHI offered better terms.

Texas does not require a demonstration that the interfering party knew that a contract was in place; it is enough if a reasonable person in the party’s position would have known about the con tract. See Kelly, 520 S.W.2d at 513; Armendariz v. Mora, 553 S.W.2d 400, 406 (Tex.Civ.App.1977). But Healix’s argument that the district court erred in its application of the standard fails for several reasons. The first is that the argument was not properly before the district judge. Healix asked the judge to rule in its favor based either on HHI’s actual knowledge of the contract or on the theory that HHI should have known about it because Healix filed a UCC financing statement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marcantel v. Michael & Sonja Saltman Family
993 F.3d 1212 (Tenth Circuit, 2021)
Moneylon v. Saul
N.D. Illinois, 2019
Healix Infusion Therapy, Incor v. HHI Infusion Services
561 F. App'x 560 (Seventh Circuit, 2014)
Richard Cacciola v. Matthew McFall
561 F. App'x 535 (Seventh Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
733 F.3d 700, 2013 WL 4317142, 2013 U.S. App. LEXIS 17125, Counsel Stack Legal Research, https://law.counselstack.com/opinion/healix-infusion-therapy-incor-v-heartland-home-infusions-inc-ca7-2013.